UBE2L3 Antibodies

Santa Cruz Biotechnology delivers a wide array of UBE2L3 monoclonal antibodies for various research applications. UBE2L3 monoclonal antibodies are suitable for techniques such as western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). UBE2L3, also known as Ubiquitin-conjugating enzyme E2 L3, plays a critical role in the ubiquitin-proteasome pathway, which is essential for protein degradation and regulation of various cellular processes. UBE2L3 is involved in the modification of target proteins through ubiquitination, influencing processes such as cell cycle regulation, DNA repair, and signal transduction. Understanding UBE2L3 function is vital for elucidating its implications in diseases, including cancer and neurodegenerative disorders. Researchers worldwide utilize UBE2L3 monoclonal antibodies to investigate protein interactions and cellular pathways. Advanced detection methods, including fluorescent conjugates like phycoerythrin (PE) and fluorescein isothiocyanate (FITC), enhance the versatility of UBE2L3 research applications. Secondary detection can also be achieved using horseradish peroxidase (HRP) conjugated antibodies for enhanced sensitivity. Santa Cruz Biotechnology monoclonal antibodies for UBE2L3 research contribute to advancing scientific understanding of cellular processes and disease mechanisms.